Increasing Patient Engagement in the Annual Well Visits Program
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03462394 |
|
Recruitment Status :
Completed
First Posted : March 12, 2018
Last Update Posted : July 8, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Annual Visit, Well Visit | Other: Current Script Other: Alternate Script Iterations |
| Study Type : | Observational |
| Actual Enrollment : | 5475 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Increasing Patient Engagement in the Annual Well Visits Program at NYU Langone Health |
| Actual Study Start Date : | February 19, 2018 |
| Actual Primary Completion Date : | July 24, 2019 |
| Actual Study Completion Date : | July 24, 2019 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Current Script Version
This arm will receive the version of the call script currently used as part of regular care at NYU Langone Health.
|
Other: Current Script
This is the version of the phone call script currently used at NYU Langone Health. |
|
Script Iterations
This arm will receive an iterated version of the script that might contain changes in wording or structure that are different from the current version of the script.
|
Other: Alternate Script Iterations
Intervention includes various iterations of the phone call script (different wording or script structure). |
- Number of scheduled annual visits [ Time Frame: 6 months ]
- Call completion rate [ Time Frame: 6 months ]Call completion rate refers to the percentage of phone calls that successfully complete all steps of the call script.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Members attributed to NYU Langone Health under a shared savings arrangement who are due for preventive services and/or screenings and are eligible to be receiving a reminder call.
Exclusion Criteria:
- N/A
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03462394
| United States, New York | |
| New York University School of Medicine | |
| New York, New York, United States, 10016 | |
| Principal Investigator: | Leora Horwitz, MD, MHS | NYU School of Medicine |
| Responsible Party: | NYU Langone Health |
| ClinicalTrials.gov Identifier: | NCT03462394 |
| Other Study ID Numbers: |
QI Patient Access Center |
| First Posted: | March 12, 2018 Key Record Dates |
| Last Update Posted: | July 8, 2021 |
| Last Verified: | July 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

